Active	Status	Sponsor type	Region	Phase	Filter
5 Active 4 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Haas, Richard H
STRIDE, NCT04535609 / 2020-002855-40: An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients	Completed	2	213	Europe, Canada, US, RoW	Mavodelpar, REN001, Placebo	Reneo Pharma Ltd	Primary Mitochondrial Myopathy	09/23	10/23
REVEAL, NCT05606614: Safety and Efficacy of TSHA-102 in Adolescent and Adult Females with Rett Syndrome ( Adult Study)	Recruiting	1/2	18	Canada, US	TSHA-102	Taysha Gene Therapies, Inc.	Rett Syndrome	01/25	01/32
NCT06152237: Safety and Efficacy of TSHA-102 in Pediatric Females with Rett Syndrome (REVEAL Pediatric Study)	Recruiting	1/2	20	Europe, Canada, US	TSHA-102	Taysha Gene Therapies, Inc.	Rett Syndrome	11/28	11/31